Stay updated on S64315 Combo with Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the S64315 Combo with Azacitidine in AML Clinical Trial page.

Latest updates to the S64315 Combo with Azacitidine in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe Record History shows a new version entry: Revision v3.3.2 replacing v3.3.1, with no visible changes to study details or results. The footer and structure appear unchanged beyond the version note. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page history shows a new version entry (v3.3.1) and removal of v3.2.0, with no changes to study records or primary content visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedDeleted the banner noting that information may be out of date due to government funding and potential operating status updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check43 days agoChange DetectedThe new screenshot shows a slightly different header and reorganized page layout on the Record History page, with no changes to the study data or records. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference12%

- Check79 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to S64315 Combo with Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the S64315 Combo with Azacitidine in AML Clinical Trial page.